Copolymer 1 in relapsing-remitting multiple sclerosis
Nicholson T, Milne R
Record ID 31998008881
English
Authors' objectives:
The authors aim to evaluate the efficacy of copolymer 1 in the treatment of relapsing-remitting multiple sclerosis (MS) compared with no treatment in the progression of the disease.
Authors' results and conclusions:
Both studies found the copolymer 1 patients had fewer relapses: 119 and 60 respectively in the copolymer 1 group, 168 and 270 in the placebo group.
Authors' recommendations:
The authors conclude that copolymer 1 is an expensive drug with small quantifiable benefits in terms of QALYs, and are unconvinced about the merits of introducing it.
Authors' methods:
Review
Details
Project Status:
Completed
URL for project:
http://www.wihrd.soton.ac.uk
Year Published:
1996
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England
MeSH Terms
- Costs and Cost Analysis
- Immunosuppressive Agents
- Multiple Sclerosis
Contact
Organisation Name:
Wessex Institute for Health Research and Development
Contact Address:
Pauline King. Wessex Institute for Health Research and Development, Boldrewood Medical School, Bassett Crescent East, Highfield, Southampton. SO16 7PX Tel. +44 1703 595661 Fax +44 1703 595662
Copyright:
Wessex Institute for Health Research and Development (WIHRD)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.